Xsolis, a Nashville-based company whose AI software helps hospitals and insurers decide which patients qualify for inpatient admission, disclosed that...
Insilico Medicine announced on July 7, 2026 that it had dosed the first patients in a Phase III clinical trial...
Illinois, Nevada, Rhode Island and Maine have now drawn a hard legal line that didn't exist a year ago: an...
Johnson & Johnson's MedTech division announced in July 2026 that it had received its first U.S. regulatory authorization for Ottava,...
Drug discovery has always been a numbers game measured in years and billions of dollars per approved medicine. Eli Lilly...
Rather than simply licensing its AI drug-design platform to outside biotechs, Schrodinger has started building its own companies around it....
Breast cancer screening has long relied on two radiologists independently reading the same mammogram, a system that catches more cancers...
URAC, the Washington, D.C.-based nonprofit that has accredited health plans and utilization-review programs for more than three decades, confirmed in...
Qure.ai, the Mumbai- and Los Angeles-based radiology AI company, announced on February 26, 2026 that the U.S. Food and Drug...
Novo Nordisk, the Danish drugmaker behind Ozempic and Wegovy, has named Amazon Web Services its preferred cloud and AI partner...
